Literature DB >> 7552814

Insulin-like growth factor-1 inhibits cell death induced by anticancer drugs in the MCF-7 cells: involvement of growth factors in drug resistance.

A Geier1, R Beery, M Haimsohn, A Karasik.   

Abstract

The involvement of growth factors in cell survival in the presence of anticancer drugs was investigated. Cell death was induced in the human breast cancer cell line MCF-7, by the structurally and mechanistically unrelated chemotherapeutic drugs puromycin, actinomycin D, 5-fluorouracil, cisplatin, and adriamycin. The effect of insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), and insulin on cell death was evaluated by two different methods: (1) trypan blue dye exclusion test and (2) lactic dehydrogenase release into the culture medium. IGF-1 inhibited cell death induced by each of the diverse drugs in a concentration-dependent manner reaching a maximal effect at 40 ng/ml. Insulin mimicked the effect of IGF-1 only at supraphysiological concentration with an optimal effect at 10,000 ng/ml. EGF had no effect on cell death up to 100 ng/ml. Our finding that IGF-1 specifically enhanced MCF-7 cell survival in the presence of different anticancer drugs suggests the involvement of growth factors in the mechanism of drug resistance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552814     DOI: 10.3109/07357909509024911

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

1.  Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents.

Authors:  D S Middlemas; B K Kihl; N M Moody
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

2.  Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.

Authors:  Jin-Rong Zhou; Lunyin Yu; Zhiming Mai; George L Blackburn
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

3.  Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy.

Authors:  J P Peyrat; F Révillion; J Bonneterre
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

4.  Biomarkers of the metabolic syndrome and breast cancer prognosis.

Authors:  Qiu-Li Zhu; Wang-Hong Xu; Meng-Hua Tao
Journal:  Cancers (Basel)       Date:  2010-04-28       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.